News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.

1Bitcoin adoption ‘booming’ while price chops: Which metrics matter most?2Bitget UEX Daily |US-Iran Conflict Escalates, Shaking Markets; Oil Prices, Gold and Silver Surge, Stock Index Futures Fall; Tech Stocks Show Mixed Performance (March 02, 2026)3SEC approval sought for JitoSOL Solana-based liquid staking token ETF
Apple's 'Big Week' Catalyst: Tactical Setup for iPhone 17e and M4 iPad Air
101 finance·2026/03/02 16:15
XRP Analyst: This Is How Bitcoin Bottom Will Play Out
TimesTabloid·2026/03/02 16:09
Oil Surge, Dow Decline: The Rapid Trading Opportunity Following U.S.-Iran Attacks
101 finance·2026/03/02 16:07
Event-Focused Examination: MKDWELL's Stock Split and Adherence to Nasdaq Standards
101 finance·2026/03/02 16:06
Analysis-US struggling to de-risk Congo's 'war zone minerals' even after pact, sources say
101 finance·2026/03/02 16:06

Dogecoin: Is trouble brewing? Why DOGE can crash 35% soon
AMBCrypto·2026/03/02 16:03

LeMaitre Vascular (LMAT) Shows Promising Technical Prospects Following Significant Golden Cross
101 finance·2026/03/02 15:57
Aluminum Prices Soar: Balancing Market Risks and Actual Supply
101 finance·2026/03/02 15:55
Should Value Investors Consider Purchasing Carter's (CRI) Shares?
101 finance·2026/03/02 15:46
Flash
16:23
Nasdaq Composite Index turns positive intradayThe Nasdaq Composite Index turned positive during the day, after previously dropping more than 1%.
16:22
Pfizer CEO said the company will "be at the forefront of testing the most aggressive approaches to maximize the potential of its obesity drug portfolio."At the TD Cowen conference, Pfizer executives emphasized that the company will adopt bold strategies to optimize its layout in the obesity treatment sector. This statement highlights Pfizer's strategic positioning in the increasingly competitive weight-loss drug market. As global demand for obesity treatment continues to grow, pharmaceutical companies are ramping up their investments in this field. Pfizer's announcement indicates that the company plans to actively innovate and test solutions, striving to secure a significant position in the obesity treatment market.
16:15
After a strong market rebound, mainstream CEX and DEX funding rates still indicate a bearish outlookBlockBeats News, March 3rd, according to Coinglass data, Bitcoin led altcoins in a strong rebound after the opening of today's U.S. stock market. However, current mainstream CEX and DEX funding rates indicate that the market is still overall bearish. Specific funding rates for mainstream coins are shown in the attached image.
BlockBeats Note: Funding rates are rates set by cryptocurrency exchanges to maintain the balance between contract prices and underlying asset prices, usually applicable to perpetual contracts. It is a mechanism for fund exchange between long and short traders, and the trading platform does not charge this fee. It is used to adjust the cost or profit of traders holding contracts to keep the contract price close to the underlying asset price.
When the funding rate is 0.01%, it represents the baseline rate. When the funding rate is greater than 0.01%, it indicates the market is generally bullish. When the funding rate is less than 0.005%, it indicates the market is generally bearish.
News